In 2020, cancer diagnoses will thrust nearly 2 million Americans into the often bewildering world of treatments and clinical trials. TrialJectory aims to help. The service uses AI to read through thousands of clinical trials and extract information about the sorts of patients the researchers are looking for. Its algorithm then matches users with the clinical trials—like the one a patient found for her Stage IV metastatic breast cancer—based on the users’ responses to a series of questions about themselves and their disease progression. Since launching in 2018, TrialJectory’s researchers have expanded the system to cover more types of cancer, adding lung cancers this summer. —Alejandro de la Garza
More Must-Reads from TIME
- Welcome to the Noah Lyles Olympics
- Melinda French Gates Is Going It Alone
- What to Do if You Can’t Afford Your Medications
- How to Buy Groceries Without Breaking the Bank
- Sienna Miller Is the Reason to Watch Horizon
- Why So Many Bitcoin Mining Companies Are Pivoting to AI
- The 15 Best Movies to Watch on a Plane
- Want Weekly Recs on What to Watch, Read, and More? Sign Up for Worth Your Time